Daniel M. Bradbury
President, Chief Executive Officer and Director
Industry: Healthcare
Overview
Daniel M. Bradbury has served as a member of our board of directors since September 2005. Mr. Bradbury has served as the Chief Executive Officer of Amylin Pharmaceuticals, Inc. since 2007, and prior to that he served as Chief Operating Officer since 2003. From 1994 to 2003 Mr. Bradbury served in various marketing, corporate development and general management roles with Amylin Pharmaceuticals. Since 2004 he has served as a member of the board of directors of Illumina, Inc. From 1984 to 1994, Mr. Bradbury served in various international sales and marketing roles with Beecham Pharmaceuticals and SmithKline Beecham Pharmaceuticals. Mr. Bradbury holds a Pharmacy degree from Nottingham University and a Diploma in Management Studies from Harrow and Ealing Colleges of Higher Education and is a member of the Royal Pharmaceutical Society of Great Britain. On December 12, 2007, Mr. Daniel M. Bradbury, has been named the lead director.
Did anyone at Microsoft ever watch the (gasp!) offensively funny show Family Guy?
Ex-Morgan Stanley exec Zoe Cruz is now heading her own hedge fund. Are Wall Street's leaders done?
Martha, Bernie and Skilling know that what you wear for court can go a long way in public perception.
Health Care
